Sign up for a free Business Victoria account to access customised information about your business and save important forms and information.
Topics on this page include:
Melbourne is in a unique position to offer investors a dynamic base for biotechnology development and success. Building on our international research and development (R&D) base the Victorian Government manages a range of programs.
Victoria's biotechnology sector offers investors a variety of opportunities to become involved in innovative research, world-renowned institutes, start-ups, and domestic and multinational pharmaceutical and life science companies.
Investors might also consider other Victorian companies that support the sector such as those dealing in bioscience instrumentation, biomaterials, chemistry, pharmaceuticals and medicine.
Investors are attracted by Victoria's extensive biotechnology advantages, including:
National companies often compete with multinationals to provide the best services; all the major players involved in venture capital have Victorian operations.
Victoria offers the full range of business support services required by biotechnology enterprises including:
Australia offers biotechnology investors a pool of highly-skilled personnel to meet present and future needs. By international comparisons, Australia performs well in terms of the number of new graduates produced at PhD level in biotechnology-related disciplines.
Victoria has the largest bioindustry workforce in Australia, making it the most attractive location for biotechnology investment. This knowledge base is supported by a world-class education and training system that provides specialised programs customised for the needs of the biotechnology sector.
Australia and Victoria's political stability has created a supportive long-term policy environment for biotechnology. Clear guidelines have been developed in consultation with industry for specific issues affecting biotechnology, such as regulations for the labelling of genetically modified food.
The Victorian Government supports the development and commercialisation of biotechnology research. Since 2001, the Government has committed more than $2 billion to investment in science, technology and innovation.
As well as a supportive policy environment, the Victorian Government offers practical support to international investors through the Department of Industry, Innovation and Regional Development (DIIRD).
Offers summaries of Victoria's six biotechnology precincts, including the Parkville Precinct, the Alfred Medical Research and Education Precinct, Monash Health Research Precinct, Werribee, Bundoora and Austin Biomedical Alliance Precincts. Also summarises the Bio21 Molecular Science and Biotechnology Institute.
Explains why Victoria offers a favourable environment for clinical research. Includes a list of major clinical research institutes.
Lists some successful applications of biotechnology pioneered in Victoria. Includes bionic ear technology, breast and stem cell research and genomics.
